Search Results 1301-1310 of 11396 for anti-TNF drugs

1. Sars-cov-2 (covid-19) vaccine, protein subunit, adjuvanted (intramuscular route) - Side effects & uses - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

2. Therapeutic Plasma Exchange With Enfortumab Vedotin And Pembrolizumab For Treatment Of Bladder Cancers - Mayo Clinic

   Treatment with enfortumab vedotin and pembrolizumab is already approved by the Food and Drug Administration for the treatment of bladder cancer, but TPE is not.

3. Study Of Cabozantinib Alone Or In Combination With Atezolizumab To Subjects With Locally Advanced Or Metastatic Solid Tumors - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... Prior treatment with cabozantinib or ICIs including anti-CTLA-4, anti-PD-1 ...

4. A Study To Evaluate Durvalumab Alone Or In Combination With Novel Agents In Subjects With NSCLC - Mayo Clinic

   Prior exposure to any anti-PD-1, anti-PD-L1, or anti-cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) antibody for the treatment of NSCLC . Any ...

5. A Study Of The Outcomes Of Natalizumab Plus Standard Steroid Treatment For High Risk Acute Graft-Versus-Host Disease - Mayo Clinic

   The purpose of this study is to assess the safety and effectiveness of combining the study drug Natalizumab (Tysabri®) with the standard use of steroid ...

6. A Study Of Tucatinib With Trastuzumab And MFOLFOX6 Versus Standard Of Care Treatment In First-line HER2+ Metastatic Colorectal Cancer (MOUNTAINEER-03) - Mayo Clinic

   This study will also test what side effects happen when participants take this combination of drugs. ... - Previous treatment with anti-HER2 therapy - Ongoing ...

7. Oncology (Medical) - Clinical trials

   The purpose of this study is to gain a better understanding of the treatment and significant morbidity associated with sinonasal cancer and identify the impact ...

8. A Study To Evaluate A New Anti-Cancer Vaccine For Patients With Non-Small Cell Lung Cancer, Given After Tumor Removal By Surgery - Mayo Clinic

   Participation eligibility · Primary tumor was removed by segmentectomy or wedge resection · Received any anti-cancer specific treatment, including radiotherapy, ...

9. APOLLO: The Study Of An Investigational Drug, Patisiran (ALN-TTR02), For The Treatment Of Transthyretin (TTR)-Mediated Amyloidosis - Mayo Clinic

   APOLLO: The Study Of An Investigational Drug, Patisiran (ALN-TTR02), For The Treatment Of Transthyretin (TTR)-Mediated Amyloidosis · More about research at Mayo ...

10. Targeted Drug Can ‘Diminish the Suffering’ of Myelofibrosis - Mayo Clinic News Network

    CHICAGO — Use of the targeted agent pacritinib significantly reduced the symptoms and burden of advanced myelofibrosis in patients, says a Mayo Clinic ...